Italia markets close in 46 minutes

ILMN Jan 2025 260.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
67,290,00 (0,00%)
In data: 03:55PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente67,29
Aperto67,40
Denaro77,50
Lettera82,40
Prezzo d'esercizio260,00
Scadenza2025-01-17
Min-Max giorno67,29 - 67,40
Contratto - Min-MaxN/D
Volume2
Open Interest44
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera